Cargando…
MyLynch: A Patient-Facing Clinical Decision Support Tool for Genetically-Guided Personalized Medicine in Lynch Syndrome
SIMPLE SUMMARY: Lynch syndrome (LS) is associated with varying cancer risks depending on which of the five causative genes harbors a pathogenic variant; however, lifestyle and medical interventions provide options to lower those risks. We developed MyLynch, a patient-facing clinical decision support...
Autores principales: | Knapp, Stephen T., Revette, Anna, Underhill-Blazey, Meghan, Stopfer, Jill E., Ukaegbu, Chinedu I., Poulin, Cole, Parenteau, Madison, Syngal, Sapna, Bae, Eunchan, Bickmore, Timothy, Hampel, Heather, Idos, Gregory E., Parmigiani, Giovanni, Yurgelun, Matthew B., Braun, Danielle |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9856567/ https://www.ncbi.nlm.nih.gov/pubmed/36672340 http://dx.doi.org/10.3390/cancers15020391 |
Ejemplares similares
-
Sebaceous neoplasms in Lynch syndrome
por: Dandapani, Monica, et al.
Publicado: (2011) -
Health behaviours and beliefs in individuals with familial pancreatic cancer
por: Underhill-Blazey, Meghan, et al.
Publicado: (2019) -
Factors associated with genetic testing distress in patients tested for Lynch Syndrome or Hereditary Breast and Ovarian Cancer Syndrome
por: Rosenblatt, Margery, et al.
Publicado: (2011) -
Adaptation and early implementation of the PREdiction model for gene mutations (PREMM(5)™) for lynch syndrome risk assessment in a diverse population
por: Mittendorf, Kathleen F., et al.
Publicado: (2021) -
Charles Lynch and His Vestigial Legacy—Workplace Lynching
por: Ramasubban, Suresh
Publicado: (2019)